Company Filing History:
2 out of 216 
1 out of 4,455 
1 out of 26 
Years Active: 2012-2016
Title: Steven Glenn Kamerling: Innovator in Pharmaceutical Compounds
Introduction
Steven Glenn Kamerling is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 4 patents to his name, Kamerling has established himself as a key figure in his area of expertise.
Latest Patents
Kamerling's latest patents focus on pyrrolo[2,3-D]pyrimidine compounds. These compounds are described as Janus Kinase (JAK) inhibitors, which have potential therapeutic applications. The patents detail pharmaceutical compositions containing these compounds and methods for their preparation. This work highlights Kamerling's commitment to advancing medical science through innovative solutions.
Career Highlights
Throughout his career, Kamerling has worked with prominent companies such as Zoetis Services LLC and Pfizer Corporation. His experience in these organizations has allowed him to contribute to significant advancements in pharmaceutical research and development. His work has not only benefited the companies he has been associated with but also the broader medical community.
Collaborations
Kamerling has collaborated with esteemed colleagues, including Mark J Mitton-Fry and Pamela J Berlinski. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Steven Glenn Kamerling is a distinguished inventor whose work in pyrrolo[2,3-D]pyrimidine compounds has the potential to impact the pharmaceutical industry significantly. His contributions and collaborations reflect his dedication to advancing medical science.